PREVENT risk → CAC refinement → LDL-C goal → therapy
Risk model: AHA PREVENT base equations, 10-year (Khan et al., Circulation 2024). Treatment thresholds: 2026 ACC/AHA multisociety dyslipidemia guideline, with the 2018 AHA/ACC cholesterol guideline and the 2022 ACC nonstatin pathway where noted. Every recommendation lists its sources and how well they have been verified. Experimental and not clinically validated. Not FDA-cleared. Not medical advice. All treatment decisions must be made by a physician. 11well home